• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Shareholders approve AstraZeneca's 2024 pay proposal for CEO Pascal Soriot despite...

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Apr 12, 2024 at 11:12: AM
via History is repeating for AstraZeneca CEO Pascal Soriot, who successfully dodged an executive pay revolt at the company’s annual meeting Thursday, echoing a similar situation that played out in 2021.

article source
 

<



Similar threads

cafead
Entellus Medical shareholders approve $662m Stryker buyout
Replies
0
Views
272
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Judge Signals He Will Approve $290 Million Settlement Between Allergan Shareholders and...
Replies
0
Views
152
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Surface warns bankruptcy possible if shareholders reject Coherus merger
Replies
0
Views
96
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Biogen shareholders vote in Susan Langer as director despite relationship with former board...
Replies
0
Views
157
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Sarissa Capital urges Alkermes shareholders to vote for its board nominees after years of...
Replies
0
Views
69
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote